【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-007174 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-22-003069 Act: 34 Size: 11 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001558370-22-003018 Act: 34 Size: 149 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-22-003021 Act: 34 Size: 614 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 5.02 Accession Number: 0001558370-22-002368 Act: 34 Size: 152 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 1.01, 2.03, 7.01, and 9.01 Accession Number: 0001558370-22-001502 Act: 34 Size: 310 KB 网页链接
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001058854-22-000006 Act: 34 Size: 41 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000919574-22-001603 Act: 34 Size: 99 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001777141-22-000002 Act: 34 Size: 82 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-039310 Act: 34 Size: 79 KB 网页链接